Benign ยท Follicular adnexalICD-10 D23

Trichilemmoma

Tricholemmoma; trichilemmal proliferation; "PTEN-trichilemmoma" (when in Cowden syndrome)

Trichilemmoma is a benign adnexal tumour with differentiation toward the outer root sheath of the hair follicle. The classical solitary lesion is a small skin-coloured to pink-tan papule on the face of an adult โ€” usually clinically dismissed as a wart, fibrous papule or BCC and only diagnosed on histology after excision. The clinically critical scenario is that of multiple facial trichilemmomas, which are pathognomonic of Cowden syndrome / PTEN hamartoma tumour syndrome (PHTS) โ€” a major cancer-predisposition syndrome with substantially elevated cancer risks, especially female breast cancer (cohort estimates about 67โ€“85%). Recognition of multiple trichilemmomas is therefore a major diagnostic opportunity for clinical genetics referral and life-saving cancer surveillance.

CurrentLast reviewed 26 April 2026
Clinical image of Trichilemmoma
Trichilemmoma. Image sourced from DermNet New Zealand. Used under CC BY-NC-ND 4.0. No endorsement implied.

Clinical features

  • Small (1โ€“5 mm), skin-coloured to pink-tan papule, sometimes hyperkeratotic, often around the nose, periorificial face and upper lip.
  • Usually multiple in syndromic context; solitary in sporadic cases.
  • Median age โ€” adolescence to adulthood; both sexes.
  • Often clinically misdiagnosed as wart, fibrous papule, sebaceous hyperplasia, BCC, syringoma.
  • The single solitary trichilemmoma is a clinical curiosity and is rarely diagnosed pre-operatively; multiple lesions are the clinically important presentation.

Histology

  • Lobular proliferation of glycogen-rich, clear / pale-staining keratinocytes extending downward from the epidermis, often in continuity with a follicular infundibulum.
  • Peripheral palisading of basal-cell-like cells with a thickened, eosinophilic, PAS-positive basement-membrane material โ€” recapitulating the outer root sheath.
  • Trichilemmal-type keratinisation (abrupt, without keratohyaline granules).
  • No atypia, mitoses or necrosis in benign trichilemmoma.
  • Differential by histology: trichilemmal carcinoma (atypia, mitoses, infiltrative growth); inverted follicular keratosis; clear-cell BCC.

Multiple trichilemmomas โ†’ Cowden syndrome

  • Multiple facial trichilemmomas are pathognomonic of Cowden syndrome / PTEN hamartoma tumour syndrome (PHTS) โ€” particularly when concentrated periorificially and accompanied by oral cobblestoning, palmoplantar pits and acral keratoses.
  • Cowden syndrome โ€” autosomal dominant cancer-predisposition syndrome with markedly elevated cancer risks, with estimates varying by cohort and ascertainment:
    • Breast carcinoma โ€” about 67โ€“85% in women.
    • Epithelial thyroid carcinoma โ€” about 6โ€“38%.
    • Endometrial carcinoma โ€” about 19โ€“28%.
    • Renal cell carcinoma โ€” about 2โ€“34%.
    • Colorectal cancer and melanoma โ€” increased above population baseline.
  • Multiple trichilemmomas in a young adult should always trigger:
    • Comprehensive history and examination for other Cowden features (oral cobblestoning, macrocephaly, cutaneous facial papules, palmoplantar pits).
    • Family history.
    • Referral to clinical genetics for germline PTEN testing.
    • Implementation of NCCN-aligned cancer surveillance โ€” see Cowden syndrome.

Management

  • Solitary trichilemmoma โ€” excisional biopsy with full histology; modest margin sufficient.
  • Multiple trichilemmomas โ€” destructive treatments for cosmesis (COโ‚‚ laser, cryotherapy, electrosurgery, dermabrasion, shave); recurrence common.
  • Topical / oral retinoids may suppress lesion development in syndromic patients.
  • Genetic counselling and germline PTEN testing for any patient with multiple trichilemmomas.
  • Implementation of cancer surveillance โ€” see Cowden syndrome.

References

  1. Hanssen AM, Fryns JP. Cowden syndrome. J Med Genet; 1995.
  2. Schaffer JV et al. Mucocutaneous neoplasms in patients with Cowden syndrome โ€” review. J Am Acad Dermatol; 2006.

Spot a correction?

If any clinical statement, citation or link on this page needs updating, please email admin@skinoncology.net with the page name, the proposed correction and the supporting source.